| Original language | English |
|---|---|
| Pages (from-to) | 1-5 |
| Number of pages | 5 |
| Journal | Expert Opinion on Pharmacotherapy |
| DOIs | |
| Publication status | E-pub ahead of print - Nov 6 2018 |
Cite this
Giannone, G., Milani, A., Geuna, E., Galizia, D., Biello, F., & Montemurro, F. (2018). What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer? Expert Opinion on Pharmacotherapy, 1-5. https://doi.org/10.1080/14656566.2018.1543406
What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer? / Giannone, Gaia; Milani, Andrea; Geuna, Elena; Galizia, Danilo; Biello, Federica; Montemurro, Filippo.
In: Expert Opinion on Pharmacotherapy, 06.11.2018, p. 1-5.Research output: Contribution to journal › Article
Giannone, G, Milani, A, Geuna, E, Galizia, D, Biello, F & Montemurro, F 2018, 'What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?', Expert Opinion on Pharmacotherapy, pp. 1-5. https://doi.org/10.1080/14656566.2018.1543406
Giannone G, Milani A, Geuna E, Galizia D, Biello F, Montemurro F. What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer? Expert Opinion on Pharmacotherapy. 2018 Nov 6;1-5. https://doi.org/10.1080/14656566.2018.1543406
@article{b9c89d5c244d4fb2b1c45dd6fa248631,
title = "What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?",
author = "Gaia Giannone and Andrea Milani and Elena Geuna and Danilo Galizia and Federica Biello and Filippo Montemurro",
year = "2018",
month = "11",
day = "6",
doi = "10.1080/14656566.2018.1543406",
language = "English",
pages = "1--5",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Taylor and Francis Ltd.",
}
TY - JOUR
T1 - What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?
AU - Giannone, Gaia
AU - Milani, Andrea
AU - Geuna, Elena
AU - Galizia, Danilo
AU - Biello, Federica
AU - Montemurro, Filippo
PY - 2018/11/6
Y1 - 2018/11/6
U2 - 10.1080/14656566.2018.1543406
DO - 10.1080/14656566.2018.1543406
M3 - Article
C2 - 30396301
SP - 1
EP - 5
JO - Expert Opinion on Pharmacotherapy
JF - Expert Opinion on Pharmacotherapy
SN - 1465-6566
ER -